| __timestamp | ADMA Biologics, Inc. | Grifols, S.A. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 180753000 |
| Thursday, January 1, 2015 | 7015946 | 224193000 |
| Friday, January 1, 2016 | 7688238 | 197617000 |
| Sunday, January 1, 2017 | 6229587 | 288320000 |
| Monday, January 1, 2018 | 3926120 | 240661000 |
| Tuesday, January 1, 2019 | 2343848 | 276018000 |
| Wednesday, January 1, 2020 | 5907013 | 294216000 |
| Friday, January 1, 2021 | 3646060 | 354881000 |
| Saturday, January 1, 2022 | 3613764 | 361140000 |
| Sunday, January 1, 2023 | 3300000 | 330551000 |
Unveiling the hidden dimensions of data
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Grifols, S.A. and ADMA Biologics, Inc. have demonstrated contrasting approaches to R&D investment. Grifols, a Spanish multinational, has consistently allocated substantial resources, with R&D expenses peaking at approximately €361 million in 2022, reflecting a 100% increase from 2014. In contrast, ADMA Biologics, a U.S.-based company, has shown a more modest investment, with a peak of around €9.5 million in 2014, followed by a gradual decline to €3.3 million in 2023. This disparity highlights Grifols' aggressive pursuit of innovation, while ADMA's strategy appears more conservative. As the biotech landscape continues to shift, these spending patterns may influence each company's competitive edge and market position.
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and ADMA Biologics, Inc.
United Therapeutics Corporation or Grifols, S.A.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Grifols, S.A.
R&D Insights: How Bio-Techne Corporation and ADMA Biologics, Inc. Allocate Funds
Research and Development Investment: Jazz Pharmaceuticals plc vs Grifols, S.A.
Blueprint Medicines Corporation or Grifols, S.A.: Who Invests More in Innovation?
R&D Insights: How Madrigal Pharmaceuticals, Inc. and ADMA Biologics, Inc. Allocate Funds
Research and Development Expenses Breakdown: Grifols, S.A. vs Opthea Limited
Who Prioritizes Innovation? R&D Spending Compared for Grifols, S.A. and Corcept Therapeutics Incorporated
Research and Development: Comparing Key Metrics for Grifols, S.A. and Ligand Pharmaceuticals Incorporated
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and ADMA Biologics, Inc.